Evidence map›Paper›PMID 41473569›Full record

ArticleF&S reports2025

Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use.

Noritoshi Enatsu, Kohyu Furuhashi, Junko Otsuki, Kunihiro Enatsu, Eri Okamoto, Shoji Kokeguchi, Masahide Shiotani

Abstract read
In one paragraph

Article in F&S reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Noritoshi EnatsuHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Kohyu FuruhashiHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Junko OtsukiHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Kunihiro EnatsuHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Eri OkamotoHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Shoji KokeguchiHanabusa Women's Clinic, Kobe City, Hyogo, Japan.
Masahide ShiotaniHanabusa Women's Clinic, Kobe City, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the optimal timing for triggering oocyte maturation by evaluating the interval from the trigger to oocyte retrieval and the subsequent in vitro fertilization outcomes. The administration of human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone agonist (GnRHa) is a critical trigger for the final maturation of oocytes within in vitro fertilization cycles. The interval between the trigger and oocyte retrieval has typically been set at 34-40 hours. However, the best timing on the basis of the type of trigger is still unclear. Design: A single-center retrospective cohort study. Subjects: A total of 59,206 oocyte retrieval cycles were investigated at our clinic between April 2010 and March 2024. Cycles with luteinizing hormone surge and those undergoing oocyte retrieval on the day after the trigger were excluded. Exposure: The interval from trigger to oocyte retrieval was from GnRHa or hCG administration to oocyte retrieval initiation. The subjects were categorized into the following two groups according to the type of oocyte maturation trigger used: GnRHa group (buserelin [600 μg] nasal spray) and hCG group (hCG [3,000-10,000 IU] or choriogonadotropin alfa [250 μg] subcutaneously). Main Outcome Measures: The primary outcome measure was the total number of mature metaphase II (MII) oocytes retrieved. Results: The GnRHa trigger group had a higher number of MII oocytes retrieved with a longer interval than with a shorter interval (7.2 ± 6.5 vs. 4.3 ± 5.3), whereas the hCG trigger group had fewer oocytes with a longer interval than with a shorter interval (4.0 ± 4.6 vs. 6.9 ± 5.8). The differences between shorter and longer intervals became more pronounced in older age groups. Although the MII ratio per oocyte did not show significant difference with the interval duration, the blastocyst formation rate and total number of blastocysts were markedly higher when the interval was longer than 36.5 hours in the GnRHa group. Conclusion: The optimal interval varies between the GnRHa trigger and the hCG trigger, with the hCG trigger associated with a shorter interval for obtaining the maximum number of MII oocytes than the GnRHa trigger.

Indexed as

GnRH agonist triggerhCG triggerin vitro fertilization (IVF)Triggering oocyte maturation

Identifiers

PMID41473569
PMCPMC12746871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.